Dr. Jason C Hadley , MD
Dermatology • Bountiful, UT
1560 Renaissance Towne Dr, Suite 210
Bountiful, UT 840107680
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on March 13, 2008; this date does not establish years in practice.
-
Published CMS data list 6,395 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J7345 — Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg: 2,800 service units.
- 17003 — Destruction of precancer skin growth, 2-14 growths: 1,000 service units.
- 88305 — Pathology examination of tissue using a microscope, intermediate complexity: 911 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 20 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 830 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Fluorouracil — 265 prescription fills, including refills.
- Hydrocortisone — 130 prescription fills, including refills.
- Triamcinolone Acetonide — 87 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 15 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 80% of clinicians listed under Dermatology in Utah (2024, 123 clinicians with data). Median for this group: 1,861. Middle half: 953 to 4,077.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 2,444 in 2020 to 6,395 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
1560 Renaissance Towne Dr
Suite 210
Bountiful, UT 840107680
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Ogden Clinic Specialty Services Llc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
Emory University School Of Medicine
2006
What Public CMS Data Show
Dermatology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
843 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $181,712 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $124,613 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
1,040 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$170,306 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $139,058.48 across 168 records.
By nature of payment
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program: $129,300.00 across 27 records.
- Travel and Lodging: $6,528.78 across 31 records.
- Food and Beverage: $3,229.70 across 110 records.
Reporting-company totals (3 largest of 19)
- Galderma Laboratories, L.P.: $101,577.76 across 77 records.
- ABBVIE INC.: $36,309.57 across 38 records.
- Novartis Pharmaceuticals Corporation: $501.80 across 23 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
20 years (graduated 2006)
CMS Doctors and Clinicians data list 2006 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2008
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Hadley has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Hadley as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Bountiful and Utah
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 80% of clinicians listed under Dermatology in Utah (2024, 123 clinicians with data). Median for this group: 1,861. Middle half: 953 to 4,077.
Too few clinicians listed under Dermatology in Bountiful have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A higher Medicare-allowed amount than 70% of clinicians listed under Dermatology in Utah (2024, 123 clinicians with data). Median for this group: $105,609. Middle half: $50,802 to $207,855.
Too few clinicians listed under Dermatology in Bountiful have Medicare Part B data for 2024 to compare.
Paid by Medicare
A higher Medicare payment amount than 65% of clinicians listed under Dermatology in Utah (2024, 123 clinicians with data). Median for this group: $74,322. Middle half: $33,246 to $144,157.
Too few clinicians listed under Dermatology in Bountiful have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
More Part D prescriptions than 85% of clinicians listed under Dermatology in Utah (2024, 128 clinicians with data). Median for this group: 373. Middle half: 170 to 679.
Too few clinicians listed under Dermatology in Bountiful have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 75% of clinicians listed under Dermatology in Utah (2024, 128 clinicians with data). Median for this group: $13,021. Middle half: $3,904 to $112,079.
Too few clinicians listed under Dermatology in Bountiful have Medicare Part D data for 2024 to compare.
6 active clinicians are listed under Dermatology with a practice address in Bountiful, UT (179 in Utah).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 162% from 2,444 in 2020 to 6,395 in 2024.
- 2020: 2,444
- 2021: 2,449
- 2022: 2,927
- 2023: 6,832
- 2024: 6,395
-
Medicare-allowed amount
Medicare-allowed amount increased 26% from $143,820 in 2020 to $181,712 in 2024.
- 2020: $143,820
- 2021: $165,383
- 2022: $183,589
- 2023: $212,560
- 2024: $181,712
-
Paid by Medicare
Paid by Medicare increased 29% from $96,832 in 2020 to $124,613 in 2024.
- 2020: $96,832
- 2021: $114,392
- 2022: $127,227
- 2023: $151,405
- 2024: $124,613
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 42% from 586 in 2020 to 830 in 2024.
- 2020: 586
- 2021: 545
- 2022: 552
- 2023: 618
- 2024: 830
-
30-day fills
30-day fills increased 39% from 750 in 2020 to 1,040 in 2024.
- 2020: 750
- 2021: 705
- 2022: 760
- 2023: 798
- 2024: 1,040
-
Part D drug cost
Part D drug cost increased 44% from $118,296 in 2020 to $170,306 in 2024.
- 2020: $118,296
- 2021: $133,607
- 2022: $350,332
- 2023: $356,038
- 2024: $170,306
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $759.34 in 2021 to $139,058.48 in 2025.
- 2021: $759.34
- 2022: $37,471.44
- 2023: $11,146.06
- 2024: $91,199.71
- 2025: $139,058.48
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 168 records totaling $139,058.48.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Galderma Laboratories, L.P. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
NEMLUVIO | General | $9,300.00 |
| Galderma Laboratories, L.P. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
NEMLUVIO | General | $9,300.00 |
| Galderma Laboratories, L.P. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
NEMLUVIO | General | $9,300.00 |
| Galderma Laboratories, L.P. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
NEMLUVIO | General | $9,300.00 |
| Galderma Laboratories, L.P. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
NEMLUVIO | General | $8,100.00 |
| Galderma Laboratories, L.P. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
NEMLUVIO | General | $8,100.00 |
| Galderma Laboratories, L.P. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
NEMLUVIO | General | $5,400.00 |
| Galderma Laboratories, L.P. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
NEMLUVIO | General | $5,400.00 |
| Galderma Laboratories, L.P. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
NEMLUVIO | General | $5,400.00 |
| Galderma Laboratories, L.P. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
NEMLUVIO | General | $5,400.00 |
| ABBVIE INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
RINVOQ | General | $4,900.00 |
| ABBVIE INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
RINVOQ | General | $4,900.00 |
| Galderma Laboratories, L.P. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
NEMLUVIO | General | $3,600.00 |
| Galderma Laboratories, L.P. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
NEMLUVIO | General | $3,600.00 |
| Galderma Laboratories, L.P. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
NEMLUVIO | General | $3,600.00 |
| Galderma Laboratories, L.P. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
NEMLUVIO | General | $3,600.00 |
| ABBVIE INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
SKYRIZI | General | $3,500.00 |
| ABBVIE INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
RINVOQ | General | $3,500.00 |
| ABBVIE INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
RINVOQ | General | $3,500.00 |
| ABBVIE INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
SKYRIZI | General | $3,500.00 |
| ABBVIE INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
RINVOQ | General | $3,500.00 |
| ABBVIE INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
RINVOQ | General | $3,150.00 |
| Galderma Laboratories, L.P. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
NEMLUVIO | General | $2,250.00 |
| ABBVIE INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
RINVOQ | General | $2,250.00 |
| Galderma Laboratories, L.P. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
— | General | $2,250.00 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J7345
Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg
|
2,800 | 12 | $2.00 | $1.66 |
|
17003
Destruction of precancer skin growth, 2-14 growths
|
1,000 | 184 | $20.00 | $6.15 |
|
88305
Pathology examination of tissue using a microscope, intermediate complexity
|
911 | 489 | $70.42 | $34.72 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
364 | 256 | $182.00 | $119.67 |
|
17000
Destruction of precancer skin growth, 1 growth
|
322 | 245 | $125.00 | $51.45 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
246 | 203 | $133.00 | $86.25 |
|
11102
Biopsy of related skin growth, first growth
|
220 | 189 | $195.00 | $90.42 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
109 | 98 | $24.00 | $15.70 |
|
11103
Biopsy of related skin growth, each additional growth
|
82 | 56 | $105.00 | $46.86 |
|
17110
Destruction of skin growth, 1-14 growths
|
69 | 63 | $171.00 | $103.96 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
59 | 59 | $167.00 | $105.88 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
47 | 47 | $254.00 | $159.32 |
|
88304
Pathology examination of tissue using a microscope, moderately low complexity
|
39 | 32 | $41.35 | $12.05 |
|
17004
Destruction of precancer skin growth, 15 or more growths
|
27 | 19 | $297.00 | $156.69 |
|
J3301
Injection, triamcinolone acetonide, not otherwise specified, 10 mg
|
26 | 12 | $9.77 | $0.99 |
|
69100
Biopsy of ear
|
17 | 15 | $164.00 | $68.51 |
|
88312
Special stained specimen slides to identify organisms including interpretation and report
|
16 | 12 | $61.05 | $28.03 |
|
96574
Application of light with debridement to destroy precancer skin growth
|
15 | 13 | $466.00 | $256.30 |
|
11900
Injection into skin growth, 1-7 growths
|
13 | 11 | $85.00 | $39.36 |
|
99202
New patient office or other outpatient visit with straightforward medical decision making, if using time, 15 minutes or more
|
13 | 13 | $111.00 | $68.43 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Fluorouracil | Fluorouracil | 265 | 8,382 | $19,083.26 | 165 |
| Hydrocortisone | Hydrocortisone | 130 | 3,575 | $773.52 | 74 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 87 | 2,184 | $957.56 | 61 |
| Clobetasol Propionate | Clobetasol Propionate | 76 | 2,032 | $2,433.85 | 35 |
| Terbinafine Hcl | Terbinafine Hcl | 56 | 2,030 | $641.67 | 23 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 43 | 1,800 | $1,327.66 | — |
| Doxycycline Hyclate | Doxycycline Hyclate | 40 | 2,557 | $1,723.15 | 20 |
| Valacyclovir | Valacyclovir Hcl | 25 | 394 | $657.44 | 11 |
| Methotrexate | Methotrexate Sodium | 18 | 571 | $194.21 | 12 |
| Metronidazole | Metronidazole | 17 | 438 | $681.80 | — |
| Spironolactone | Spironolactone | 17 | 1,530 | $398.36 | — |
| Dapsone | Dapsone | 15 | 810 | $1,075.26 | — |
| Dupixent Pen | Dupilumab | 15 | 392 | $58,363.28 | — |
| Minoxidil | Minoxidil | 14 | 1,110 | $334.67 | — |
| Rinvoq | Upadacitinib | 12 | 360 | $81,660.62 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 207N00000X
A dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - DERMATOLOGY
I20100810000839
UT
6406980655
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Ogden Clinic Specialty Services Llc
1560 Renaissance Towne Dr, Bountiful, UT 840107666
Phone: 8013976100
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Physician Assistant
Physician Assistant (Certified)
Dermatology - MOHS-Micrographic Surgery
Doctor of Medicine (M.D.)
Physician Assistant
Physician Assistant (Certified)
Physician Assistant
Physician Assistant (Certified)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
NPI status registered as active in NPPES database
Registered at PO BOX 5546, DENVER, CO 802175546 (Tel: 8013976100)
Registered at 1560 RENAISSANCE TOWNE DR, SUITE 210, BOUNTIFUL, UT 840107680 (Tel: 8013976100)
Recorded as JASON HADLEY, MD
Dermatology (license number reported to NPPES: UT 6851419-1205)
NPI status registered as active in NPPES database
Registered at 1560 RENAISSANCE TOWNE DR, SUITE 210, BOUNTIFUL, UT 840107680 (Tel: 8013976100)
Registered at 4650 HARRISON BLVD, OGDEN, UT 844034303 (Tel: 8014753000)
Recorded as JASON HADLEY, MD
Dermatology (license number reported to NPPES: UT 6851419-1205)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Dermatology Specialists in Bountiful
- Dr. John Robison, MD
- Anthony Johnson
- Dr. Amy Curtis, MD
- Dr. Tanya Christensen, MD
- Dr. Brooks Bahr, MD
Mailing Address
Po Box 5546
Denver, CO 802175546
Phone: 8013976100